Parul Singh is a product-driven founder and investor with a background in engineering, product strategy, and analytics. Parul spent the past five years on the investing team at Founder Collective, a tech-focused, early-stage seed fund where she covered Boston and NYC, evaluated over 3,000 companies, and spearheaded the firm’s investments in Embark Veterinary, Broadlume, Running Tide, HumanFirst, Flume Health, and HealthNote. Prior to investing, she spent close to a decade as an engineer and product manager at the NYTimes.com, Inc. and Fast Company, and she was the founder of a learning analytics company. At Initialized, Parul will focus her investing efforts on software companies, with a special interest in the areas of healthtech, SaaS, and analytics. Parul has an undergraduate degree from Harvard College and an MBA from MIT.

Parul primarily invests in analytics, SaaS, and health-tech.

Broadlume, Embark Veterinary, Flume Health, HumanFirst, Running Tide, and HealthNote